Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,242,795
-$8,735 QoQ
Shares Held
3,432
-3.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,546
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RESOURCES MANAGEMENT CORP /CT/ /ADV holds $58,736,749 across 9 Drug Manufacturers - General names. AMGN ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
85,694 | $21,564,038 | |
| 2 | JNJ |
Johnson & Johnson
|
57,899 | $14,704,609 | |
| 3 | LLY |
ELI LILLY & Co
|
6,910 | $8,288,061 | |
| 4 | MRK |
Merck & Co., Inc.
|
58,507 | $7,518,149 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
20,373 | $2,573,924 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
27,375 | $1,577,347 | |
| 7 | AMGN |
Amgen Inc
This page
|
3,432 | $1,242,795 | |
| 8 | PFE |
Pfizer Inc
|
39,710 | $956,216 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,242,795 | 3,432 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,251,530 | 3,557 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,190,426 | 3,637 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,172,541 | 4,155 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,530,070 | 5,480 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,768,046 | 5,675 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $1,461,147 | 5,606 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,631,993 | 5,065 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,452,892 | 4,650 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,245,321 | 4,380 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,016,710 | 3,530 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $967,267 | 3,599 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $803,712 | 3,620 | Shares | Sole | 2023-08-16 | |
| 2023-03-31 | $743 | 17,155 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,041,892 | 3,967 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $870,494 | 3,862 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $917,727 | 3,772 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $917,465 | 3,794 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $889,531 | 3,954 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,098,975 | 5,168 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,627,031 | 6,675 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,004,662 | 8,057 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,792,916 | 7,798 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,886,629 | 7,423 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,754,326 | 7,438 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,497,769 | 7,388 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||